We identify potential investments through deep sector research and assess our capability in full partnership with their management teams to build market-leading and innovative companies.

2024

SePRO

SePRO is a leader in developing sustainable solutions that protect, preserve, and restore nature.

2023

Roboyo

Roboyo is the world's largest specialist hyper-automation company.

2022

LXO Group

LXO Group is a leading specialty pharma platform with market differentiating capabilities in Late Lifecycle Management, Digital,
in-licensing and M&A

2022

qinecsa

Qinecsa is a leading global provider of pharmacovigilance software and outsourced services to support its global pharma customers across their clinical safety and PV commitments.

2022

Arietta.AI

Arietta.AI is an expert in crafting transformative AI solutions for life sciences companies.

2020

noden pharma

Noden Pharma DAC is a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a broad range of therapeutic areas in international markets. The company focuses its resources on acquiring and optimizing established medicines.

2020

Essential pharma group

Essential is a portfolio company of a European focused private equity fund. Simon Cottle led the origination of the investment in the company and was co-lead on the execution of the transaction